[PDF][PDF] Quantification of tremor severity with a mobile tremor pen

T Zajki-Zechmeister, M Kögl, K Kalsberger, S Franthal… - Heliyon, 2020 - cell.com
Background An objective evaluation of tremor severity is necessary to document the course
of disease, the efficacy of treatment, or interventions in clinical trials. Most available objective …

Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.

T Thielgen, F Foerster, G Fuchs, A Hornig… - Electromyography …, 2004 - europepmc.org
Monitoring systems enable the long-term registration of tremor in patients with Parkinson's
disease This method is useful in the objective measurement of tremor during the course of …

Re-emergent tremor in Parkinson's disease: clinical and accelerometric properties

Z Aytürk, R Yilmaz, MC Akbostanci - Journal of Clinical Neuroscience, 2017 - Elsevier
Re-emergent tremor (RET) and the classical parkinsonian rest tremor were considered as
two different phenomena of the same central tremor circuit. However, clinical and …

Metoprolol compared with propranolol in the treatment of essential tremor

WC Koller, N Biary - Archives of neurology, 1984 - jamanetwork.com
• We analyzed effects of metoprolol tartrate and propranolol hydrochloride on 23 patients
with essential tremor. Tremor was assessed by patient self-evaluation, clinical scoring, and …

Randomized, double‐blind, 3‐month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor

P Navan, LJ Findley, JAR Jeffs… - … : official journal of the …, 2003 - Wiley Online Library
We compared the antitremor effect of pramipexole, pergolide, or placebo in Parkinson's
disease (PD). A double‐blind, randomly controlled, parallel protocol was deployed to …

Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine

G Wang, SC Fowler - Psychopharmacology, 2001 - Springer
Rationale: Both harmaline and physostigmine are known to produce whole-body tremors in
rodents, yet there is little quantitative information on the differential frequency characteristics …

Budipine in Parkinson's tremor

H Reichmann - Journal of the neurological sciences, 2006 - Elsevier
It is generally accepted that patients with a tremor-dominant type of idiopathic Parkinson's
disease progress more slowly than the ones with the rigid-akinetic type. On the other hand …

Provocation of Parkinsonian tremor

J Raethjen, K Austermann, K Witt… - … : official journal of the …, 2008 - Wiley Online Library
Classical Parkinsonian rest tremor typically fluctuates over time and can be provoked by
stressful situations. We quantified and compared the influence of different provocation …

[HTML][HTML] Are we making progress in the understanding of tremor in Parkinson's disease?

M Hallett, G Deuschl - Annals of neurology, 2010 - ncbi.nlm.nih.gov
In his essay on the Shaking Palsy, 1 James Parkinson noted the presence of tremor as a
cardinal feature:“Involuntary tremulous motion, with lessened muscular power, in parts not in …

Cabergoline in the treatment of Parkinson's disease

P Pastor, E Tolosa - Neurologia (Barcelona, Spain), 2003 - europepmc.org
Cabergoline (1-[(6-allelylergolin-8 beta-yl) carbonyl]-1-[3-(dimethylamino) propyl]-3-ethyl-
urea) is a new agonist of the D2 dopaminergic receptors used in the treatment of Parkinson's …